Article

Human T Cell Leukemia Virus Type 1 Up‐Regulation after Simian Immunodeficiency Virus–1 Coinfection in the Nonhuman Primate

Section of Infectious Diseases, Tulane University, New Orleans, Louisiana, United States
The Journal of Infectious Diseases (Impact Factor: 6). 03/2007; 195(4):562-71. DOI: 10.1086/510914
Source: PubMed

ABSTRACT

The effects that human T cell leukemia virus (HTLV) type 1 and simian immunodeficiency virus (SIV) coinfection have on HTLV-1 dynamics and disease progression were tested in a nonhuman primate model. Seven rhesus macaques were experimentally inoculated with HTLV-1, and a persistent infection was established. Coinfection with SIV/smB670 resulted in increased HTLV-1 p19 antigens in peripheral blood mononuclear cells and HTLV-1 proviral loads. Circulating CD2(+) and CD8(+) T lymphocytes increased over preinoculation levels, along with a progressive decrease in CD4(+) T cells, typical for terminal SIV disease. Finally documented was the striking emergence of up to 19% of HTLV-associated "flower cell" lymphocytes in the circulation, as seen in patients with adult T cell leukemia/lymphoma. CD8(+)CD25(+) T cell subpopulation increases were positively correlated with flower cell appearance and suggested their possible role in this process. We conclude that SIV may have the potential to up-regulate HTLV-1 and disease expression.

Download full-text

Full-text

Available from: Vicki L Traina-Dorge, Aug 14, 2015
  • Source
    • "Experimental dual infections with SIV in NHPs have provided useful insights into viral dynamics and host immunity. Dual infection with SIV is believed to potentiate STLV-I/HTLV-I-related disease but not exacerbate SIV burden or disease progression (Fultz et al., 1990, 1999; Traina-Dorge et al., 2007). In these co-infection studies, macaques were given a high-titre inoculum to maximize the chance of infection and accelerate progression to disease, which does not necessarily reflect the situation in naturally acquired infection in macaques or in humans. "
    [Show abstract] [Hide abstract]
    ABSTRACT: The infection dynamics and pathology of a retrovirus may be altered by one or more additional virus(es). To investigate this we characterised proviral load, biodistribution and the immune response in Macaca fascicularis naturally-infected with combinations of SRV-2 and STLV-I. Since the mesenteric lymph node (MLN) and the spleen have been previously implicated in response to retroviral infection, the morphology and immunopathology of these tissues were assessed. Our data revealed a significant change in SRV-2 biodistribution in macaques infected with STLV-I. Pathological changes were greater in the MLN and spleen of STLV-I infected and co-infected macaques, compared with the other groups. Immune cell populations in co-infected macaque spleens were increased and there was an atypical distribution of B-cells. These findings suggest that the infection dynamics of each virus in a co-infected individual may be affected to a different extent and that STLV-I appears to be responsible for enhancing the biodistribution and associated pathological changes of SRV-2 in macaques.
    Preview · Article · Nov 2012 · Journal of General Virology
  • [Show abstract] [Hide abstract]
    ABSTRACT: Simian Virology is the first text to comprehensively cover all currently known simian viruses. Chapters provide an overview of nonhuman primate models of medically important viral diseases as well as natural infections of nonhuman primates with human and animal viruses. The text covers a variety of topics including primate models of medically important viral diseases such as AIDS, hypotheses on the origins of epidemic forms of HIV, and viral diseases caused by non-simian viruses in both wild and captive primates.
    No preview · Article · Sep 2009
  • Source
    [Show abstract] [Hide abstract]
    ABSTRACT: Coinfection with human T-cell lymphotropic virus type 2 (HTLV-2) and human immunodeficiency virus type 1 (HIV-1) has been reported to have either a slowed disease course or to have no effect on progression to AIDS. In this study, we generated a coinfection animal model and investigated whether HTLV-2 could persistently infect macaques, induce a T-cell response, and impact simian immunodeficiency virus SIVmac251-induced disease. We found that inoculation of irradiated HTLV-2-infected T cells into Indian rhesus macaques elicited humoral and T-cell responses to HTLV-2 antigens at both systemic and mucosal sites. Low levels of HTLV-2 provirus DNA were detected in the blood, lymphoid tissues, and gastrointestinal tracts of infected animals. Exposure of HTLV-2-infected or naïve macaques to SIVmac251 demonstrated comparable levels of SIVmac251 viral replication, similar rates of mucosal and peripheral CD4+ T-cell loss, and increased T-cell proliferation. Additionally, neither the magnitude nor the functional capacity of the SIV-specific T-cell-mediated immune response was different in HTLV-2/SIVmac251 coinfected animals versus SIVmac251 singly infected controls. Thus, HTLV-2 targets mucosal sites, persists, and importantly does not exacerbate SIVmac251 infection. These data provide the impetus for the development of an attenuated HTLV-2-based vectored vaccine for HIV-1; this approach could elicit persistent mucosal immunity that may prevent HIV-1/SIVmac251 infection.
    Full-text · Article · Mar 2010 · Journal of Virology
Show more